Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.

Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani F.

BJU Int. 2010 Jan;105(2):185-90. doi: 10.1111/j.1464-410X.2009.08698.x. Epub 2009 Jul 8.

2.

Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience.

Debruyne FM, Witjes WP.

Mol Urol. 2000 Fall;4(3):251-6;discussion 257.

PMID:
11062381
3.
6.

Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.

Fair WR, Betancourt JE.

Mol Urol. 2000 Fall;4(3):241-8;discussion 249-50.

PMID:
11062380
7.

Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study.

Montironi R, Diamanti L, Santinelli A, Galetti-Prayer T, Zattoni F, Selvaggi FP, Pagano F, Bono AV.

Pathol Res Pract. 1999;195(4):201-8.

PMID:
10337657
8.

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.

Silberstein JL, Poon SA, Sjoberg DD, Maschino AC, Vickers AJ, Bernie A, Konety BR, Kelly WK, Eastham JA.

BJU Int. 2015 Jul;116(1):50-6. doi: 10.1111/bju.12676. Epub 2015 Apr 17.

10.

Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy.

Zhao B, Yerram NK, Gao T, Dreicer R, Klein EA.

Urol Oncol. 2015 Apr;33(4):164.e19-23. doi: 10.1016/j.urolonc.2015.01.001. Epub 2015 Feb 7.

PMID:
25665510
11.

Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.

Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP 3rd, Crawford ED, Thompson IM Jr, Klein EA.

Urology. 2012 Mar;79(3):633-7. doi: 10.1016/j.urology.2011.11.019.

12.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Isbarn H, Wanner M, Salomon G, Steuber T, Schlomm T, Köllermann J, Sauter G, Haese A, Heinzer H, Huland H, Graefen M.

BJU Int. 2010 Jul;106(1):37-43. doi: 10.1111/j.1464-410X.2009.09134.x. Epub 2009 Dec 11.

13.
14.

Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?

Boorjian SA, Bianco FJ Jr, Scardino PT, Eastham JA.

BJU Int. 2005 Oct;96(6):773-6.

15.

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Denham JW, Steigler A, Lamb DS, Joseph D, Turner S, Matthews J, Atkinson C, North J, Christie D, Spry NA, Tai KH, Wynne C, D'Este C.

Lancet Oncol. 2011 May;12(5):451-9. doi: 10.1016/S1470-2045(11)70063-8.

PMID:
21440505
16.

Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence.

Inoue H, Nishimura K, Yamaguchi S, Nonomura N, Hara T.

Int J Clin Oncol. 2015 Feb;20(1):171-5. doi: 10.1007/s10147-014-0681-7. Epub 2014 Mar 21.

PMID:
24652165
17.

Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy.

Pu XY, Wang XH, Wu YL, Wang HP.

J Cancer Res Clin Oncol. 2007 Aug;133(8):555-62. Epub 2007 Apr 25.

PMID:
17457611
18.

Neoadjuvant hormonal therapy in carcinoma of the prostate.

Lee HH, Warde P, Jewett MA.

BJU Int. 1999 Mar;83(4):438-48. Review.

PMID:
10210568
19.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

20.

Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.

Rieken M, Shariat SF, Kluth LA, Fajkovic H, Rink M, Karakiewicz PI, Seitz C, Briganti A, Rouprêt M, Loidl W, Trinh QD, Bachmann A, Pourmand G.

Eur Urol. 2015 Dec;68(6):949-56. doi: 10.1016/j.eururo.2015.05.038. Epub 2015 Jun 3.

PMID:
26050111

Supplemental Content

Support Center